This pro-death phenotype was reversed through either SCD1 overexpression or exogenous OA supplementation, confirming the critical anti-ferroptotic role of SCD1 and MUFA biosynthesis in HNSCC survival. This evidence concerns the gene SCD and head and neck squamous cell carcinoma.